Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses

Salomé Leibundgut-Landmann, Fabiola Osorio, Gordon Douglas Brown, Caetano Reis e Sousa

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

The C-type lectin receptor dectin-1 functions as a pattern recognition receptor for beta-glucans and signals via Syk kinase but independently of the Toll-like receptor (TLR) pathway to regulate expression of innate response genes. Dectin-1 signaling can promote activation of dendritic cells (DCs), rendering them competent to prime Th1 and Th17 responses. Here we show that dectin-1-activated DCs can also prime cytotoxic T-lymphocyte (CTL) responses. DCs exposed to a dectin-1 agonist induced antigen-specific expansion of TCR transgenic CD8(+) T cells and their differentiation into CTLs in vitro. Dectin-1 agonist also acted as an adjuvant for CTL crosspriming in vivo, eliciting potent CTL responses that protected mice from tumor challenge. In vitro but not in vivo, CTL crosspriming was dependent on IL-12 p70, which was produced by dectin-1-activated DCs in response to IFN-gamma secreted by newly activated CD8(+) T cells. The dectin-1/Syk pathway is thus able to couple innate immune recognition of beta-glucans to all branches of the adaptive immune system, including CD4(+) T-helper cells, B cells, and CD8(+) cytotoxic T cells. These data highlight the ability of non-TLR receptors to bridge innate and adaptive immunity and suggest that dectin-1 agonists may constitute useful adjuvants for immunotherapy and vaccination.
Original languageEnglish
Pages (from-to)4971-4980
Number of pages10
JournalBlood
Volume112
Issue number13
Early online date25 Sep 2008
DOIs
Publication statusPublished - 15 Dec 2008

Fingerprint

T-cells
Dendritic Cells
T-Lymphocytes
Cytotoxic T-Lymphocytes
beta-Glucans
C-Type Lectins
Pattern Recognition Receptors
dectin 1
Immune system
Toll-Like Receptors
Adaptive Immunity
Interleukin-12
Helper-Inducer T-Lymphocytes
Innate Immunity
Immunotherapy
Tumors
Cell Differentiation
Immune System
Vaccination
B-Lymphocytes

Keywords

  • animals
  • antigen presentation
  • cross-priming
  • dendritic cells
  • immunity
  • immunization
  • interleukin-12
  • intracellular signaling peptides and proteins
  • lymphocyte activation
  • membrane proteins
  • mice
  • nerve tissue proteins
  • protein-tyrosine kinases
  • signal transduction
  • T-lymphocytes, cytotoxic

Cite this

Leibundgut-Landmann, S., Osorio, F., Brown, G. D., & Reis e Sousa, C. (2008). Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood, 112(13), 4971-4980. https://doi.org/10.1182/blood-2008-05-158469

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. / Leibundgut-Landmann, Salomé; Osorio, Fabiola; Brown, Gordon Douglas; Reis e Sousa, Caetano.

In: Blood, Vol. 112, No. 13, 15.12.2008, p. 4971-4980.

Research output: Contribution to journalArticle

Leibundgut-Landmann, S, Osorio, F, Brown, GD & Reis e Sousa, C 2008, 'Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses', Blood, vol. 112, no. 13, pp. 4971-4980. https://doi.org/10.1182/blood-2008-05-158469
Leibundgut-Landmann, Salomé ; Osorio, Fabiola ; Brown, Gordon Douglas ; Reis e Sousa, Caetano. / Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. In: Blood. 2008 ; Vol. 112, No. 13. pp. 4971-4980.
@article{0dbae3d76fc04af4a4190e95475a2217,
title = "Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses",
abstract = "The C-type lectin receptor dectin-1 functions as a pattern recognition receptor for beta-glucans and signals via Syk kinase but independently of the Toll-like receptor (TLR) pathway to regulate expression of innate response genes. Dectin-1 signaling can promote activation of dendritic cells (DCs), rendering them competent to prime Th1 and Th17 responses. Here we show that dectin-1-activated DCs can also prime cytotoxic T-lymphocyte (CTL) responses. DCs exposed to a dectin-1 agonist induced antigen-specific expansion of TCR transgenic CD8(+) T cells and their differentiation into CTLs in vitro. Dectin-1 agonist also acted as an adjuvant for CTL crosspriming in vivo, eliciting potent CTL responses that protected mice from tumor challenge. In vitro but not in vivo, CTL crosspriming was dependent on IL-12 p70, which was produced by dectin-1-activated DCs in response to IFN-gamma secreted by newly activated CD8(+) T cells. The dectin-1/Syk pathway is thus able to couple innate immune recognition of beta-glucans to all branches of the adaptive immune system, including CD4(+) T-helper cells, B cells, and CD8(+) cytotoxic T cells. These data highlight the ability of non-TLR receptors to bridge innate and adaptive immunity and suggest that dectin-1 agonists may constitute useful adjuvants for immunotherapy and vaccination.",
keywords = "animals, antigen presentation, cross-priming, dendritic cells, immunity, immunization, interleukin-12, intracellular signaling peptides and proteins, lymphocyte activation, membrane proteins, mice, nerve tissue proteins, protein-tyrosine kinases, signal transduction, T-lymphocytes, cytotoxic",
author = "Salom{\'e} Leibundgut-Landmann and Fabiola Osorio and Brown, {Gordon Douglas} and {Reis e Sousa}, Caetano",
year = "2008",
month = "12",
day = "15",
doi = "10.1182/blood-2008-05-158469",
language = "English",
volume = "112",
pages = "4971--4980",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses

AU - Leibundgut-Landmann, Salomé

AU - Osorio, Fabiola

AU - Brown, Gordon Douglas

AU - Reis e Sousa, Caetano

PY - 2008/12/15

Y1 - 2008/12/15

N2 - The C-type lectin receptor dectin-1 functions as a pattern recognition receptor for beta-glucans and signals via Syk kinase but independently of the Toll-like receptor (TLR) pathway to regulate expression of innate response genes. Dectin-1 signaling can promote activation of dendritic cells (DCs), rendering them competent to prime Th1 and Th17 responses. Here we show that dectin-1-activated DCs can also prime cytotoxic T-lymphocyte (CTL) responses. DCs exposed to a dectin-1 agonist induced antigen-specific expansion of TCR transgenic CD8(+) T cells and their differentiation into CTLs in vitro. Dectin-1 agonist also acted as an adjuvant for CTL crosspriming in vivo, eliciting potent CTL responses that protected mice from tumor challenge. In vitro but not in vivo, CTL crosspriming was dependent on IL-12 p70, which was produced by dectin-1-activated DCs in response to IFN-gamma secreted by newly activated CD8(+) T cells. The dectin-1/Syk pathway is thus able to couple innate immune recognition of beta-glucans to all branches of the adaptive immune system, including CD4(+) T-helper cells, B cells, and CD8(+) cytotoxic T cells. These data highlight the ability of non-TLR receptors to bridge innate and adaptive immunity and suggest that dectin-1 agonists may constitute useful adjuvants for immunotherapy and vaccination.

AB - The C-type lectin receptor dectin-1 functions as a pattern recognition receptor for beta-glucans and signals via Syk kinase but independently of the Toll-like receptor (TLR) pathway to regulate expression of innate response genes. Dectin-1 signaling can promote activation of dendritic cells (DCs), rendering them competent to prime Th1 and Th17 responses. Here we show that dectin-1-activated DCs can also prime cytotoxic T-lymphocyte (CTL) responses. DCs exposed to a dectin-1 agonist induced antigen-specific expansion of TCR transgenic CD8(+) T cells and their differentiation into CTLs in vitro. Dectin-1 agonist also acted as an adjuvant for CTL crosspriming in vivo, eliciting potent CTL responses that protected mice from tumor challenge. In vitro but not in vivo, CTL crosspriming was dependent on IL-12 p70, which was produced by dectin-1-activated DCs in response to IFN-gamma secreted by newly activated CD8(+) T cells. The dectin-1/Syk pathway is thus able to couple innate immune recognition of beta-glucans to all branches of the adaptive immune system, including CD4(+) T-helper cells, B cells, and CD8(+) cytotoxic T cells. These data highlight the ability of non-TLR receptors to bridge innate and adaptive immunity and suggest that dectin-1 agonists may constitute useful adjuvants for immunotherapy and vaccination.

KW - animals

KW - antigen presentation

KW - cross-priming

KW - dendritic cells

KW - immunity

KW - immunization

KW - interleukin-12

KW - intracellular signaling peptides and proteins

KW - lymphocyte activation

KW - membrane proteins

KW - mice

KW - nerve tissue proteins

KW - protein-tyrosine kinases

KW - signal transduction

KW - T-lymphocytes, cytotoxic

U2 - 10.1182/blood-2008-05-158469

DO - 10.1182/blood-2008-05-158469

M3 - Article

VL - 112

SP - 4971

EP - 4980

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -